You are currently viewing a new version of our website. To view the old version click .

Advancements in Antipsychotics

Special Issue Information

Dear Colleagues,

Antipsychotic medications are the primary pharmacotherapeutic option used in the treatment of severe mental illness, including schizophrenia and bipolar disorder; however, their use is expanding to several other populations and disease states. Antipsychotics, while efficacious, exhibit a high degree of interindividual effectiveness as well as side effects leading to non-adherence. The exact mechanisms underlying the heterogeneous response to antipsychotic treatment remain to be fully elucidated. The aim of this Special Issue is to collect and publish findings on recent advancements in antipsychotic research. This Special Issue is especially focused on omic-type studies of antipsychotic treatment outcomes but can also include imaging studies, other mechanism-type studies or adjunct treatment studies. Submissions can include original research or review articles.

Dr. Kyle Burghardt
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • antipsychotics
  • mechanisms
  • omic
  • efficacy
  • side effects
  • pathways
  • clinical
  • pre-clinical

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Biomedicines - ISSN 2227-9059Creative Common CC BY license